Typical atrioventricular (AV) node re-entrant tachycardia (AVNRT) occurs in patients with dual AV nodal pathway, a rapid pathway used for retrograde conduction and a slow pathway used for the anterograde conduction. In sinus rhythm, the patients have generally the signs of conduction through the rapid pathway with a normal or short PR interval. The purpose of the study was to evaluate the prevalence of patients with 1 st degree AV block and with AVNRT and their clinical characteristics.
Conclusions:
The occurrence of AVNRT in patients with 1 st degree AV block is exceptional and concerns old patients. Ablation of slow pathway might be safely performed without a need of pacemaker implantation. Transitory 2 nd degree AVB can be noted the day after ablation.
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In how many patients with Wolff-Parkinson-White syndrome-related adverse presentation isoproterenol infusion was required to reproduce the arrhythmia?
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Electrophysiological study is the main method for the detection of patients with a Wolff-Parkinson-White syndrome (WPW) at risk of adverse presentation (resuscitated ventricular fibrillation (VF), documented life-threatening arrhythmia): the protocol is debated. The purpose of the study was to look in how many patients with WPW-related adverse presentation, atrial fibrillation (AF) or atrial tachycardia with the shortest RR cycle length (CL) with 1/1 conduction over accessory pathway (AP)<250 msec was induced in control state (CS) and when isoproterenol was required.
Methods: 63 patients, mean age 38±18, were referred for WPW-related adverse presentation (VF 6, other 56). EPS included in CS atrial pacing and measurement of the shortest CL with 1/1 conduction over AP and programmed stimulation with 1 and 2 extrastimuli. AP effective refractory period (ERP) was determined. In absence of induction of a tachycardia with a CL <250 msec, isoproterenol (0.02 to 1 µg. min -1 ) was infused to increase sinus rate to 130 bpm; the protocol was repeated.
Results: Mean shortest CL conducted over AP was 223±30 msec in CS, 192±25 msec after isoproterenol. APERP was 225±29 msec in CS, 191±19 msec after isoproterenol. Atrioventricular orthodromic tachycardia (AVRT) was induced in 34 patients (54%), antidromic tachycardia (ATD) in 13 (21%), AF in 43 (68%). Criteria for a malignant form (induction of AF or ATD with a shortest CL <250 mesc) were noted in 42 patients (67%) in CS and were obtained after isoproterenol in remaining 21 patients (33%). Among these patients, 12 had inducible tachycardia in CS (AVRT (n=6), ATD (n=3), AF (n=3) but the shortest CL was >240 msec. A tachycardia was only induced after isoproterenol in 9 patients (14%).
Conclusions:
Infusion of isoproterenol should be systematic when WPW is evaluated. EPS performed only in CS missed at least 14% of patients at risk of life-threatening arrhythmias who had no inducible supraventricular tachyarrhythmia and 33% of patients with a WPW without the classical criteria for a malignant form. Isoproterenol increased the sensitivity of EPS for the detection of malignant form from 67 to 100%.
